|Bid||136.64 x 800|
|Ask||136.50 x 800|
|Day's Range||135.30 - 137.05|
|52 Week Range||81.90 - 137.84|
|Beta (5Y Monthly)||0.88|
|PE Ratio (TTM)||38.48|
|Earnings Date||Aug 11, 2020|
|Forward Dividend & Yield||2.16 (1.60%)|
|Ex-Dividend Date||Jun 11, 2020|
|1y Target Est||131.29|
On Tuesday, August 11, Broadridge Financial Soln (NYSE: BR) will release its latest earnings report. Benzinga's outlook for Broadridge Financial Soln is included in the following report.Earnings and Revenue Wall Street expects EPS of $2.09 and sales around $1.32 billion. In the same quarter last year, Broadridge Financial Soln reported EPS of $1.72 on revenue of $1.21 billion. The Wall Street estimate would represent a 21.51% increase in the company's earnings. Here's how the company's reported EPS has stacked up against analyst estimates in the past:Quarter Q3 2020 Q2 2020 Q1 2019 Q4 2019 EPS Estimate 1.72 0.72 0.71 1.71 EPS Actual 1.67 0.53 0.68 1.72 Revenue Estimate 1.25 B 995.23 M 979.61 M 1.22 B Revenue Actual 1.25 B 968.70 M 948.60 M 1.21 B Stock Performance Over the last 52-week period, shares are up 6.93%. Given that these returns are generally positive, long-term shareholders are probably content going into this earnings release.View more earnings on BRDon't be surprised to see the stock move on comments made during its conference call. Broadridge Financial Soln is scheduled to hold the call at 11:00:00 ET and can be accessed here: https://edge.media-server.com/mmc/p/c9h8im7gSee more from Benzinga * Stocks That Hit 52-Week Highs On Wednesday * Stocks That Hit 52-Week Highs On Monday(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Broadridge (BR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
89% of the S&P 500’s market cap have already reported second-quarter results. Moderna, Pfizer, and AstraZeneca’s efforts to develop a Covid-19 vaccine enter Phase 3. And Apple splits its stock.